Enhanced apoptosis in transformed human lung fibroblasts after exposure to sodium butyrate

In Vitro Cellular and Developmental Biology - Animal

Volumn 32, Issue 8, 1996, Pages 505-513

  Thomas, Graham L ^b   Henley, Anna ^a   Rowland, Tami C ^a   Sahai, Animesh ^a   Griffin, Martin ^b   Birckbichler, Paul J ^a,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

cell cycle; differentiation; human cells; transglutaminase

Indexed keywords

BUTYRIC ACID; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANEUPLOIDY; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL STRUCTURE; CELL TRANSFORMATION; CULTURE MEDIUM; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; SIMIAN VIRUS; ULCERATIVE COLITIS;

SIMIAE; SIMIAN VIRUS;

EID: 0029856101     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02723054     Document Type: Article

References (50)

1. Arundel, C. M.; Kenney, S. M.; Leith, J. T., et al. Contrasting effects of the differentiating agent sodium butyrate on recovery processes after X-irradiation in heterogenous human colon tumor cells. Int. J. Radiat. Oncol. Biol. Phys. 12:959-968; 1986.
2. Barile, M. F. Mycoplasma contamination of cell cultures. In: Kruse, P. F., Jr.; Patterson, M. K., Jr., eds. Tissue culture: methods and applications. New York: Academic Press; 1973:729-735.
3. Barnes, R. N.; Bungay, P. J.; Elliott, B. M., et al. Alterations in the distribution and activity of transglutaminase during tumour growth and metastasis. Carcinogenesis 6:459-463; 1985.
4. Birckbichler, P. J.; Orr, G. R.; Conway, E., et al. Transglutaminase activity in normal and transformed cells. Cancer Res. 37:1340-1344; 1977.
5. Birckbichler, P. J.; Orr, G. R.; Patterson, M. K., Jr. Differential transglutaminase distribution in normal rat liver and rat hepatoma. Cancer Res. 36:2911-2914; 1976.
6. Birckbichler, P. J.; Orr, G. R.; Patterson, M. K., Jr., et al. Increase in proliferative markers after inhibition of transglutaminase. Proc. Natl. Acad. Sci. USA 78:5005-5008; 1981.
7. Birckbichler, P. J.; Orr, G. R.; Patterson, M. K., Jr., et al. Enhanced transglutaminase activity in transformed human lung fibroblast cells after exposure to sodium butyrate. Biochim. Biophys. Acta 723:27-34; 1983.
8. Calabresse, C.; Venturini, L.; Ronco, G., et al. Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line. Biochem. Biophys. Res. Commun. 195:31-38; 1993.
9. Chung, Y. S.; Song, I. S.; Erickson, R. H., et al. Effect of growth and sodium butyrate on brush border membrane-associated hydrolases in colorectal cancer cell lines. Cancer Res. 45:2976-2982; 1985.
10. Compton, M. M.; Haskill, J. S.; Cidlowski, J. A. Analysis of glucocorticoid actions on rat thymocyte deoxyribonucleic acid by fluorescence-activated flow cytometry. Endocrinology 122:2158-2164; 1988.
11. Corra, S.; Kazakoff, K.; Mogaki, M., et al. Modification of antigen expression in human and hamster pancreatic cancer cell lines induced by sodium butyrate. Teratogenesis, Carcinogenesis and Mutagenesis 13:199-215; 1993.
12. D'Argenio, G.; Cosenza, V.; Sorrentini, I., et al. Butyrate, mesalamine, and factor XIII in experimental colitis in the rat: effects on transglutaminase activity. Gastroenterology 106:399-404; 1994.
13. D'Argenio, G.; Sorrentini, I.; Cosenza, V., et al. Serum and tissue transglutaminase correlates with the severity of inflammation in induced colitis in the rat. Scand. J. Gastroenterol. 27:111-114; 1992.
14. Delcros, J. G.; Bard, S.; Roch, A. M., et al. Transglutaminase activity and putrescine-binding capacity in cloned cell lines with different metasiatic potential. FEBS Lett. 196:325-330; 1986.
15. Dyson, J. E. D.; Daniel, J.; Surrey, C. R. The effect of sodium butyrate on the growth characteristics of human cervix tumour cells. Br. J. Cancer 65:803-808; 1992.
16. El-Alaoui, S.; Mian, S.; Lawry, J., et al. Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis). FEBS Lett. 311:174-178; 1992.
17. Fesus, L; Thomazy, V.; Autuori, F., et al. Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action. FEBS Lett. 245:150-154; 1989.
18. Fesus, L.; Thomazy, V.; Falus, A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224:104-108; 1987.
19. Goldberg, Y. P.; Leaner, V. D.; Parker, M. I. Elevation of large-T antigen by sodium butyrate treatment of SV40-transformed WI-38 fibroblasts. J. Cell. Biochem. 49:74-81; 1992.
20. Graham, K. A.; Buick, R. N. Sodium butyrate induces differentiation in breast cancer cell lines expressing the estrogen receptor. J. Cell. Physiol. 136:63-71; 1988.
21. Greenberg, C. S.; Birckbichler, P. J.; Rice, R. H. Transglutaminases: multifunctional crosslinking enzymes that stabilize tissues. FASEB J. 5:3071-3077; 1991.
22. Hague, A.: Elder, D. J. E.; Hicks, D. J., et al. Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer 60:400-406; 1995.
23. Hague, A.; Manning, A. M.; Hanlon, K. A., et al. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer 55:498-505; 1993.
24. Halgunset, J.; Lamvik, T.; Espevik, T. Butyrate effects on growth, morphology, and fibronectin production in PC-3 prostatic carcinoma cells. Prostate 12:65-77; 1988.
25. Hand, D.; Elliott, B. M.; Griffin, M. Correlation of changes in transglutaminase activity and polyamine content of neoplastic tissue during the metastatic process. Biochim. Biophys. Acta 930:432-437; 1987.
26. Kamech, N.; Hill, A.-M.; Seif, R., et al. Butyrate converts rat 3T3 fibroblasts into giant cells. Exp. Cell Res. 162:326-334; 1986.
27. Kaufmann, S. H.; Desnoyers. S.; Ottaviano, Y., et al. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:3976-3985; 1993.
28. Kerr, J. F. R.; Wyllie, A. H.: Currie, A. R Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26:239-257; 1972.
29. Kim, Y. S.; Tsao, D.; Siddiqui, B., et al. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer 45:1185-1192; 1980.
30. Knight, R. L.; Hand, D.; Piacentini, M., et al. Characterisation of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis. Eur. J Cell Biol. 60:210-216; 1993.
31. Knight, C. R. L.; Rees, R. C.; Elliott, B. M., et al. The existence of an inactive form of transglutaminase within metastasising tumours. Biochim. Biophys. Acta 1053:13-20; 1990.
32. Knight, C. R. L.; Rees, R. C.; Griffin, M. Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim. Biophys. Acta 1096:312-318; 1991.
33. Kruh, J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem. 42:65-82; 1982.
34. Kruh, J.; Defer, N.; Tichonicky, L. Action moleculaire et cellulaire du butyrate. C.R. Soc. Biol. 186:12-25; 1992.
35. Lee, K. N.; Birckbichler, P. J.; Patterson, M. K., Jr., et al. Induction of cellular transglutaminase biosynthesis by sodium butyrate. Biochim. Biophys. Acta 928:22-28; 1987.
36. Lowry, O. H.; Rosebrough, N. J.; Fair, A. L., et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
37. Lu, X-; Walker, T.; MacManus. J. P., et al. Differentiation of HT-29 human colonic adenocarcinoma cells correlates with increased expression of mitochondrial RNA: effects of trehalose on cell growth and maturation. Cancer Res. 52:3718-3725: 1992.
38. Martin, S. J.; Bonham, A. M.: Cotter, T. G. The involvement of RNA and protein synthesis in programmed cell death (apoptosis) in human leukemia HL-60 cells. Biochem. Soc. Trans. 18:634-636; 1990.
39. Nathan, D. F.; Burkhart, S. R.; Morin, M. J. Increased cell surface EGF receptor expression during the butyrate-induced differentiation of human HCT-116 colon tumor cell clones. Exp. Cell Res. 190:76-84; 1990.
40. Piacentini, M.; Fesus, L.; Farrace, M. G , et al. The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis) Eur. J. Cell Biol. 54:246-254; 1991.
41. Rocchi, P.; Ferren, A. M.; Simone, G., et al. Growth inhibitory and differentiating effects of sodium butyrate on human neuroblastoma cells in culture. Anticancer Res. 12:917-920; 1992.
42. Rowe, W. A.; Bayless, T. M. Colonic short-chain fatty acids: fuel from the lumen? Gastroenterology 103:336-339; 1992.
43. Scheppach, W. Effect of short chain fatty acids on gut morphology and function. Gut supplement 1:S35-S38; 1994.
44. Scheppach, W.; Sommer, H.; Kirchner, T., et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51-56; 1992.
45. Schmidt, R.; Michel, S.; Shroot, B., et al. Plasma membrane transglutaminase and cytosolic transglutaminase form distinct envelope-like structures in transformed human keratinocytes. FEBS Lett. 229:193-196; 1988.
46. Schwartzmann, R. A.; Cidlowski, J. A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14:133-151; 1993.
47. Silk, D. B. A. Fibre and enterai nutrition. Gut 30:246-264; 1989.
48. Thomas, G. L.; Griffin, M.; Henley, A., et al. Induction of apoptosis and transglutaminase in transformed human lung fibroblasts following sodium butyrate treatment. FASEB J. 8:A1356; 1994.
49. Toscani, A.; Soprano, D. R.; Soprano, K. J. Molecular analysis of sodium butyrate-induced growth arrest. Oncogene Res. 3:223-238; 1988.
50. Wyllie, A. H. Cell death: a new classification separating apoptosis from necrosis. In: Bowden, I. D.; Lockshin, R. A., eds. Cell death in biology and pathology. London: Chapman and Hall; 1981:9-34.